ELII: Preclinical Development of Novel Reickettsiosis Therapeutics Targeting EPAC1

Project: Research project

Project Details

StatusFinished
Effective start/end date4/10/143/31/17

Funding

  • University of Texas Health Science Center-Houston: $2,372,242.00